The need to find key opinion leaders (KOLs) is common to every medical affairs department. From providing internal guidance on product strategy to presenting clinical trial information at a conference, the right KOLs are essential for a drug’s success. Healthcare professionals and payers such as insurance companies demand evidence and recommendations from experts to adopt new treatments. 

Dimensions is a powerful platform that uses artificial intelligence to link millions of scientific data points, allowing medical affairs staff to find the best KOLs for their projects. With just one search, users find a broad range of rich information, including full-text publications, clinical trial data, funding sources, and even the social media impact generated by the expert. 

Since finding KOLs is a frequently performed and important activity, the Dimensions team created a new tool that makes it even easier. It features a simple and intuitive user interface that accesses all of the data Dimensions has to offer. 

As shown below, there are just two fields used to conduct a search. The “area of interest” field highlighted in red prompts users to select a Therapy area, and to the right, the Inclusion criteria drop-down can be set to broad or narrow. Choosing broad executes a full-text search while narrow limits the results to searching title and abstract information.

The search results can be narrowed down with filters and sorted by several attributes. 

When KOL candidates are discovered, in-depth expert profiles present a timeline (shown below) with links to rich information, including: 

  • Publication overview
  • Field of research
  • Concepts
  • Experience
  • Network
  • Lists of all research documents

The profiles link to Altmetric data, enabling users to understand the attention generated from their publications. 

Discovering new KOLs is becoming more important than ever in medical affairs, and Dimensions can help make it more efficient. Learn more about how Dimensions can be used for Medical Affairs in our webinar, or contact us for more information.